MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-26-2026
Delcath Systems DPO Ratio 2011-2026 | DCTH
Annual DPO Ratio Delcath Systems
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56 | 58.2 | 871 | 707 | 656 | 1.01 K | 2.3 K | 2.79 K | 2 K | 394 | 224 | 938 | 458 | 8.58 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.58 K | 56 | 1.5 K |
Quarterly DPO Ratio Delcath Systems
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119 | 87.1 | 41.4 | - | 117 | 143 | 126 | - | 590 | 1.03 K | 1.12 K | - | 912 | 839 | 2.6 K | - | 485 | 555 | 1.23 K | - | 861 | 964 | 3.69 K | - | 2.4 K | 2.4 K | 5.82 K | - | 3.02 K | 3.2 K | 3.59 K | - | 2.04 K | 2.6 K | 925 | - | 484 | 361 | 361 | - | 288 | 189 | 354 | - | 1.37 K | 1.03 K | 652 | - | 2.31 K | 160 | 2.24 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.82 K | 41.4 | 1.32 K |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ClearPoint Neuro
CLPT
|
33.2 | $ 11.1 | -0.72 % | $ 314 M |  USA |
 |
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | USA |
 |
Electromed
ELMD
|
47.8 | $ 25.81 | 0.98 % | $ 218 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Eargo
EAR
|
124 | - | - | $ 10.2 M | USA |
 |
Helius Medical Technologies
HSDT
|
362 | $ 2.16 | - | $ 1.31 M | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
29.6 | - | -0.97 % | $ 54.4 M | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.45 | 3.29 % | $ 129 M |  France |
 |
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | USA |
 |
Cytosorbents Corporation
CTSO
|
107 | $ 0.61 | -2.42 % | $ 38 M | USA |
 |
LivaNova PLC
LIVN
|
68 | $ 57.59 | -2.51 % | $ 3.14 B |  Britain |
 |
LENSAR
LNSR
|
146 | $ 5.48 | -1.44 % | $ 65.5 M | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
Invacare Corporation
IVC
|
75.6 | - | - | $ 24.7 M | USA |
 |
Insulet Corporation
PODD
|
22.5 | $ 167.53 | -2.25 % | $ 11.8 B | USA |
 |
Inspire Medical Systems
INSP
|
103 | $ 48.25 | -12.02 % | $ 1.42 B | USA |
 |
IRIDEX Corporation
IRIX
|
71.9 | $ 1.05 | -3.23 % | $ 17.8 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Sintx Technologies
SINT
|
223 | $ 2.42 | - | $ 6.71 M | USA |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 17.04 | 7.98 % | $ 400 M | USA |
 |
Butterfly Network
BFLY
|
51.3 | $ 4.82 | -0.52 % | $ 1.02 B | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
TransMedics Group
TMDX
|
15.5 | $ 94.93 | -2.21 % | $ 3.23 B | USA |
 |
Tandem Diabetes Care
TNDM
|
35.7 | $ 19.42 | -2.26 % | $ 1.32 B | USA |
 |
Globus Medical
GMED
|
33.1 | $ 90.03 | -0.63 % | $ 12.2 B | USA |
 |
NanoVibronix
NAOV
|
58.2 | - | - | $ 1.08 M | USA |
 |
CONMED Corporation
CNMD
|
57.3 | $ 36.64 | 2.12 % | $ 1.14 B | USA |
 |
Stryker Corporation
SYK
|
70.1 | $ 295.25 | 1.5 % | $ 113 B | USA |
 |
Integer Holdings Corporation
ITGR
|
28.9 | $ 85.85 | 2.26 % | $ 2.98 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
58.1 | $ 82.91 | -0.5 % | $ 48.5 B | USA |
 |
Pulmonx Corporation
LUNG
|
60.4 | $ 1.27 | -4.51 % | $ 51.7 M | USA |
 |
MiMedx Group
MDXG
|
54.8 | $ 3.64 | 0.83 % | $ 538 M | USA |
 |
Myomo
MYO
|
34.8 | $ 0.88 | 1.69 % | $ 36.8 M | USA |